Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U36100MH2012PTC226495 Incorporated 27 January 2012 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2018
₹24.6 Lakh
▲ 16% YoY
Net profit · FY 2018
₹88,042
Net margin 3.6%
EBITDA · FY 2018
₹1.39 Lakh
EBITDA margin 5.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings

About Amico Pharmaceuticals Private Limited

Data last updated:

Amico Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 January 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36100MH2012PTC226495. Its GSTIN is 10AAMCA4864H1ZR (Bihar).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Amico Pharmacuitical Private Limited. It is led by directors Mani Ranjan and Indira Mani Ranjan.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Flat No. 1/502 Geeta Prangan Chsl Geeta Nagar 7 Mira Bhayander Road Mira Road (East), Thane, Maharashtra, India – 401107.

As per the financials filed for FY 2018, the company reported a revenue of ₹24.6 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹88,042 (net margin 3.6%) and EBITDA of ₹1.39 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 168% over three years.

As per MCA filings, the company has open charges of ₹10 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amicopharmaindia.com.

Company Details of Amico Pharmaceuticals Private Limited
CIN U36100MH2012PTC226495
Registration Number 226495
Incorporation Date 27 January 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Flat No. 1/502 Geeta Prangan Chsl Geeta Nagar 7 Mira Bhayander Road Mira Road (East), Thane, Maharashtra, India – 401107
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Amico Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Amico Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Amico Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Amico Pharmaceuticals Private Limited

The main business activity of Amico Pharmaceuticals is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Amico Pharmaceuticals Private Limited FY 2021 filings available

Amico Pharmaceuticals Private Limited reported revenue of ₹24.6 Lakh (up 16% YoY) for FY 2018.

Revenue · FY 2018
₹24.6 Lakh ▲ 16%
Net profit · FY 2018
₹88,042 margin 3.6%
EBITDA · FY 2018
₹1.39 Lakh margin 5.7%

Compounded Annual Growth Rate (CAGR) of Amico Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 168%
EBITDA CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 208%

Revenue has grown at a compounded annual rate (CAGR) of 168% over three years, including 16% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Amico Pharmaceuticals Private Limited

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹24.6 Lakh••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹1.39 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹88,042••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Amico Pharmaceuticals Private Limited

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin5.7%••••••••••••
Net Profit Margin3.6%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amico Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vikman Pharmaceutical Private Limited₹24.64 Lakh (FY 2024)••••••••••••Kolkata, West Bengal, India
Rambler Tradex Private Limited₹24.64 Lakh (FY 2023)••••••••0.0%••••New Delhi, Delhi, India
Gnanamayee Pharmaceuticals Private Limited₹24.63 Lakh (FY 2024)••••••••••••Hyderabad, Telangana, India
Lotus Cardiac Care Private Limited₹24.61 Lakh (FY 2024)••••••••19.0%••••Vadodara, Gujarat, India
Rucha Pharmaceuticals Pvt Ltd₹24.61 Lakh (FY 2022)••••••••••••Ahmedabad, Gujarat, India
Amico Pharmaceuticals Private Limited this company₹24.6 Lakh (FY 2018)••••••••16.0%••••Thane, Maharashtra, India
South Point Marketing Private Limited₹24.59 Lakh (FY 2025)••••••••-59.0%••••Chennai, Tamil Nadu, India
Ceca Clinical Innovations Private Limited₹24.59 Lakh (FY 2018)••••••••-72.0%••••Allepey, Kerala, India
Wondamed Pharmaceuticals Private Limited₹24.57 Lakh (FY 2025)••••••••16.0%••••Jaipur, Rajasthan, India
Jayam Prolife Private Limited₹24.55 Lakh (FY 2024)••••••••••••Mumbai, Maharashtra, India
Salveca Healthcare Private Limited₹24.53 Lakh (FY 2025)••••••••273.0%••••Noida, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Amico Pharmaceuticals by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals Private Limited is audited by SAMDARSHI & ASSOCIATES for the financial year 2018.

NameStatusAppointment DateCessation Date
SAMDARSHI & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mani RanjanDirector27 Jan 201214 Years 8 MonthsCurrent
Indira Mani RanjanDirector27 Jan 201214 Years 8 MonthsCurrent

Ownership and Shareholding of Amico Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Amico Pharmaceuticals Private Limited

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Vijaya Bank₹0.10 Cr
Latest charge details
DateLenderAmountStatus
08 Sep 2017Vijaya Bank₹10 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Amico Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Amico Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Indira Mani Ranjan was appointed as Director on 27 Jan 2012.

AGM
Amico Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Amico Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.
Charges
A charge with Vijaya Bank amounted to Rs. 10.00 Lakh with Charge ID 100144017 was registered on 08 Sep 2017.
Appointed
Indira Mani Ranjan was appointed as Director.
Appointed
Mani Ranjan was appointed as Director.
Incorporation
27 Jan 2012
Amico Pharmaceuticals Private Limited was registered on 27 Jan 2012 with Roc Mumbai & aged 14 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Amico Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Amico Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Amico Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAMCA4864H1ZRBiharActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Amico Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amico Pharmaceuticals Private Limited

Amico Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 January 2012 (14+ years old) and is registered under CIN U36100MH2012PTC226495.

Amico Pharmaceuticals reported revenue of ₹24.6 Lakh for FY 2018 (up 16% YoY).

Amico Pharmaceuticals has 2 current directors:

Amico Pharmaceuticals reported a net profit of ₹88,042 (net margin 3.6%) and EBITDA of ₹1.39 Lakh (EBITDA margin 5.7%) for FY 2018, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Amico Pharmaceuticals is 168% over three years. In the latest year (FY 2018) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Amico Pharmaceuticals is 10AAMCA4864H1ZR, registered in Bihar.

The CIN (Corporate Identification Number) of Amico Pharmaceuticals is U36100MH2012PTC226495. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amico Pharmaceuticals was incorporated on 27 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Amico Pharmaceuticals by revenue are Vikman Pharmaceutical Private Limited, Rambler Tradex Private Limited, Gnanamayee Pharmaceuticals Private Limited, Lotus Cardiac Care Private Limited, Rucha Pharmaceuticals Pvt Ltd and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).

Indira Mani Ranjan was appointed as Director on 27 Jan 2012. Mani Ranjan was appointed as Director on 27 Jan 2012.

Amico Pharmaceuticals can be reached through the website amicopharmaindia.com. Its registered office is in Thane, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available